WWMSC
EVFM

Wagner Wealth Management (South Carolina)’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed – – 702
2021
Q4 		$0 Buy
+2
New +$17 ﹤0.01% 721

Other funds holding EVFM

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s EVFM Position: Q1 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2022, closing a stake of 2 shares.

Wagner Wealth Management (South Carolina) first reported a position in EVFM in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 68 funds tracked by Wall St. Rank hold EVFM as of Q1 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 2 Evofem Biosciences, Inc. Common Stock shares in Q1 2022.
  • Wagner Wealth Management (South Carolina) first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q1 2022, filed 16 May 2022.